08/23/2023
Shore Capital and Baden Hill advised on an Equity Fundraising to raised £6.15 Million for Oxford BioDynamics plc
Oxford BioDynamics plc (OBD) is a biotechnology company developing targeted clinical diagnostic tests for immune health, based on the EpiSwitch® 3D genomics platform.